SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Road Walker who wrote (13324)2/8/2010 9:20:53 AM
From: Lane31 Recommendation  Read Replies (1) | Respond to of 42652
 
Or the Euro's could choose not to take drugs I suppose. I doubt that will happen.

They could and probably would choose to take drugs from other suppliers. Your conclusion ignores foreign competitors. When prices are raised, sensible buyers look elsewhere. There may be some drugs that they can't get elsewhere but you can't assume that US drug companies have absolute pricing power.



To: Road Walker who wrote (13324)2/8/2010 11:28:34 AM
From: skinowski  Read Replies (1) | Respond to of 42652
 
Or the drug companies could choose to go out of business.

Or they, at the very least, may be forced to cut their R&D.

If that will happen, I would hope that they would, at least, focus on new antibiotics and anti-virals. We can get by, imo, for a while, with our current statins and beta blockers and NSAID's. Falling behind the curve with infections could prove to be terrible.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News